Latest Stock Market News

Emkay Global Financial Services recommends adding Tata Consultancy Services (TCS) with a target price of Rs 3,900. Currently, TCS is priced at Rs 3,440. For the quarter ending December 2024, TCS reported a total income of Rs 65,216 crore and a net profit of Rs 12,444 crore. Promoters hold 71.77% stake in the company.

Shares of Indian pharma companies, including Aurobindo Pharma, Laurus Labs, IPCA Labs, and Lupin, fell up to 7% after U.S. President Donald Trump hinted at imminent tariffs on pharmaceutical imports. Speaking aboard Air Force One, Trump said pharma would be treated as a separate tariff category, reversing earlier expectations that the sector would remain exempt from trade restrictions.

Samir Arora of Helios Capital discusses market volatility, the impact of US tariffs, and effective investment strategies amid economic uncertainties. He emphasizes cautious optimism for India’s market performance while highlighting potential correction in US equities and the need for tactical investment decisions.

The shares of National Aluminium Company (NALCO) dipped the highest, falling by 6% to an intraday low of Rs 162.40, followed by Vedanta shares, which fell by 5.7% to Rs 414.35 in early trade and Hindalco shares falling by 5.4% to Rs 617.15.

Peter McGuire advises focusing on gold in the short run as a safe haven due to its strong rally and the stable US dollar. Despite a broad selloff in commodities, especially oil and industrial metals, gold remains a good investment for the next couple of weeks, particularly with Asia s strong demand for physical gold.

Anshul Saigal discusses the potential shift in market dynamics, highlighting the underperformance of the real economy compared to tech. He emphasizes the upcoming opportunities in sectors like banking, textiles, value retail, capital goods, and CDMO, driven by macroeconomic changes and the evolving tariff situation.

Stock Market Crash Today: Indian stock markets experienced a sharp drop as renewed recession fears and President Trump s new tariff announcements sparked a global selloff. The Sensex fell 836 points, with broad-based selling pulling down sectoral indices including metal, pharma, and IT. Investor sentiment was affected by potential tariffs targeting the pharma sector and heightened global uncertainty.

Goldman Sachs remains confident in Zomato, maintaining a buy rating with a target price of Rs 310 despite recent stock declines and concerns about Blinkit. They argue that the quick commerce arm s issues are overblown, and Zomato s food delivery business is undervalued. Last week, Goldman acquired 60.07 lakh Zomato shares worth Rs 281 crore.

UBS has upgraded Bank of Baroda to a Buy rating due to stable outlook and attractive valuations, raising the target price to Rs 290. Loan growth is projected at 12% from FY25 to FY27, with NIM compression expected to remain modest, offering a favorable risk-reward scenario.

The United States has imposed a 26% tariff on Indian exports as a countermeasure to India s own barriers on American goods. This move impacts key sectors differently, with pharmaceuticals exempted while electronics and gems are heavily affected. The strategic realignment could benefit India s textiles and footwear industries.